Pembrolizumab - branded as Keytruda - will be funded from October 1, 2024, for eligible people with advanced triple-negative ...

Second treatment, Bevacizumab is used on liver and ovarian cancer - and would be funded by next April. Pharmac Chief Medical Officer, David Hughes, says offering them will have a wide effect, and ...

Every day eight New Zealanders are diagnosed with a form of blood cancer, including leukaemia, lymphoma, or * Leukaemia and ...

Associate Health Minister with responsibility for Pharmac David Seymour has welcomed the increased availability of medicines for Kiwis resulting from the Government’s increased investment in Pharmac.

Women suffering an incurable form of breast cancer have been given “life-changing” hope after Pharmac agreed to fund a wonder ...

Pharmac has opened public consultation to propose funding for Enhertu, which treats for HER2-positive metastatic breast cancer. Its clinical trials have seen the risk of death reduced by a third, and ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.

EMERYVILLE, Calif., August 13, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and six months ended June 30, 2024 and provides a business update.

The Greens welcome today's long-coming announcement by Pharmac of consultation to remove the special authority renewal ...